Fundz

Access Vascular, Inc. Secures $20 Million in Series B Financing

PRIVATEMar 03, 2021

Amount Raised

$20 Million

Round Type

Series B

BedfordBiotechnology

Description

Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a $15 million commitment, with existing investors also participating.

Quick answer

Access Vascular, Inc. raised $20 Million in a Series B round, dated March 3, 2021. Access Vascular, Inc. is based in Bedford, Massachusetts, United States.

How much did Access Vascular, Inc. raise?
Access Vascular, Inc. raised $20 Million in a Series B round on March 3, 2021.
What does Access Vascular, Inc. do?
Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis.
Where is Access Vascular, Inc. based and how big is it?
Access Vascular, Inc. is based in Bedford, Massachusetts, United States.
Who are the decision-makers at Access Vascular, Inc?
Fundz holds 2 contacts at Access Vascular, Inc., including the Administration Manager. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Access Vascular, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Your Super, Inc. raised $4M (Seed) on April 16, 2021.
  • Hazel Technologies raised $68M on April 16, 2021.
  • Liquidia raised $22M on April 16, 2021.
  • uLab Systems, Inc. raised $41M on April 16, 2021.
  • pulseData, Inc. raised $17M on April 16, 2021.
  • Molecular Assemblies raised $24M (Series A) on April 15, 2021.

Who to call at Access Vascular, Inc., and when

A new round usually means Access Vascular, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Access Vascular, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Access Vascular, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Access Vascular, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Access Vascular, Inc.

Location

175 MIDDLESEX TURNPIKE, SUITE 1A

Bedford, Massachusetts, United States

About

Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, the company manufactures intravenous catheters from a hydrophilic material which retains significant amounts of water. Engineered to mimic the body’s natural chemistry, Access Vascular catheters are designed to evade the foreign body response and complications that come with it. Our cleared products are HydroPICC®and HydroMID®. For more information, please visit www.accessvascularinc.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Access Vascular, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKatie M., Administration Manager hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Access Vascular, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Access Vascular, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.